Serum carbohydrate antigen elevations in endometrial adenocarcinomas: Characterization of DU‐PAN‐2 expression as a tumor marker

Abstract

It is suggested that DU-PAN-2 tends to be produced more in well-differentiated components of EMACs than in poorly differentiated ones. Since approximately half the cases with EMAC were serologically positive for DU-PAN-2 in stage III + IV, the marker is believed to be of much use for monitoring the cases with an extrauterine extent.